Driving force of COVID-19 among people living with HIV in Wuhan, China

References

• Blanco, J. L., Ambrosioni, J., Garcia, F., Martínez, E., Soriano, A., Mallolas, J., & Miro, J. M. (2020). COVID-19 in patients with HIV: Clinical case series. The Lancet HIV, https://doi.org/10.1016/s2352-3018(20)30111-9
   Google Scholar
• Chen, G., Wu, D. I., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., & Zhang, X. (2020). Clinical and immunological features of severe and moderate coronavirus disease 2019. Journal of Clinical Investigation, 130(5), 2620–2629. https://doi.org/10.1172/jci137244
   PubMed Web of Science ®Google Scholar
• Commission., W. M. H. (2020). Update on Covid-19 Outbreak in Wuhan (Updated on May 18th, 2020). http://wjw.wuhan.gov.cn/ztzl_28/fk/tzgg/202005/t20200519_1324187.shtml, accessed on May 24th, 2020
   Google Scholar
• Currier, J. S., & Havlir, D. V. (2018). CROI 2018: Complications of HIV infection and antiretroviral therapy. Topics in Antiviral Medicine, 26(1), 22–29. PMID: 29727294; PMCID: PMC5963934
   PubMedGoogle Scholar
• Etienne, N., Karmochkine, M., Slama, L., Pavie, J., Batisse, D., Usubillaga, R., Letembet, V. A., Brazille, P., Canouï, E., Slama, D., & Joumaa, H. (2020). HIV infection and COVID-19: Risk factors for severe disease. Aids (London, England), 34(12), 4. https://doi.org/10.1097/QAD.0000000000002651
   Web of Science ®Google Scholar
• Giamarellos-Bourboulis, E. J., Netea, M. G., Rovina, N., Akinosoglou, K., Antoniadou, A., Antonakos, N., Damoraki, G., Gkavogianni, T., Adami, M. E., Katsaounou, P., & Ntaganou, M. (2020). Complex immune dysregulation in COVID-19 patients with severe Respiratory failure. Cell Host & Microbe, https://doi.org/10.1016/j.chom.2020.04.009
   Google Scholar
• Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., & Marrama, D. (2020). Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell, https://doi.org/10.1016/j.cell.2020.05.015
   Google Scholar
• Guan, W. J., Ni, Z. Y., Hu, Y., Liang, W. H., Ou, C. Q., He, J. X., Liu, L., Shan, H., Lei, C. L., Hui, D. S., & Du, B. (2020). Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicine, https://doi.org/10.1056/NEJMoa2002032
   Google Scholar
• Guo, W., Ming, F., Feng, Y., Zhang, Q., Mo, P., Liu, L., Gao, M., Tang, W., & Liang, K. (2020). Patterns of HIV and SARS-CoV-2 co-infection in wuhan, China. Journal of the International AIDS Society, 23(7), e25568. https://doi.org/10.1002/jia2.25568
   PubMed Web of Science ®Google Scholar
• Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., & Cheng, Z. (2020). Clinical features of patients infected with 2019 novel coronavirus in wuhan, China. The Lancet, https://doi.org/10.1016/s0140-6736(20)30183-5
   Google Scholar
• Jiang, H., Zhou, Y., & Tang, W. (2020). Maintaining HIV care during the COVID-19 pandemic. The Lancet HIV, 7(5), e308–e309. https://doi.org/10.1016/s2352-3018(20)30105-3
   PubMed Web of Science ®Google Scholar
• Li, R., Yin, K., Zhang, K., Wang, Y. Y., Wu, Q. P., Tang, S. B., & Cheng, J. D. (2020a). Application prospects of virtual autopsy in forensic pathological investigations on COVID-19. Fa Yi Xue Za Zhi, 36(2), 149–156. https://doi.org/10.12116/j.issn.1004-5619.2020.02.001
   PubMedGoogle Scholar
• Li, S., Jiang, L., Li, X., Lin, F., Wang, Y., Li, B., Jiang, T., An, W., Liu, S., Liu, H., & Xu, P. (2020b). Clinical and pathological investigation of patients with severe COVID-19. JCI Insight, 5(12), https://doi.org/10.1172/jci.insight.138070
   Google Scholar
• Liu, Z., Long, W., Tu, M., Chen, S., Huang, Y., Wang, S., Zhou, W., Chen, D., Zhou, L., Wang, M., & Wu, M. (2020). Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19. Journal of Infection, 81(2), https://doi.org/10.1016/j.jinf.2020.03.054
   Google Scholar
• National Health Commission. (2020). Diagnosis and treatment of COVID-19 pneumonia in China (the 7th edition). In Chinese Published March 3, 2020. Accessed April 4, 2020. http://wwwnhcgovcn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989shtml?spm=C73544894212P5951194134100
   Google Scholar
• Ong, E. Z., Chan, Y. F. Z., Leong, W. Y., Lee, N. M. Y., Kalimuddin, S., Mohideen, S. M. H., Chan, K. S., Tan, A. T., Bertoletti, A., Ooi, E. E., & Low, J. G. H. (2020). A dynamic immune response shapes COVID-19 progression. Cell Host & Microbe, https://doi.org/10.1016/j.chom.2020.03.021
   Google Scholar
• Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., & Zhao, Y. (2020). Clinical characteristics of 138 hospitalized patients With 2019 novel coronavirus–infected Pneumonia in wuhan, China. Jama, https://doi.org/10.1001/jama.2020.1585
   Web of Science ®Google Scholar
• Xu B., Fan C.-Y., Wang A.-L., Zou Y.-L., Yu Y.-H., He C., Xia W.-G., Zhang J.-X., Miao Q. (2020a). Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in wuhan, China. Journal of Infection, 81(1), https://doi.org/10.1016/j.jinf.2020.04.012
   Google Scholar
• Xu, X., Sun, J., Nie, S., Li, H., Kong, Y., Liang, M., Hou, J., Huang, X., Li, D., Ma, T., & Peng, J. (2020b). Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China. Nature Medicine, 26(8), https://doi.org/10.1038/s41591-020-0949-6
   Google Scholar
• Zhang, X., Tan, Y., Ling, Y., Lu, G., Liu, F., Yi, Z., Jia, X., Wu, M., Shi, B., Xu, S., & Chen, J. (2020). Viral and host factors related to the clinical outcome of COVID-19. Nature, 583(7816), 437–440. https://doi.org/10.1038/s41586-020-2355-0
   PubMed Web of Science ®Google Scholar